4//SEC Filing
Stewart Robert A 4
Accession 0001723128-19-000042
CIK 0001723128other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:49 PM ET
Size
5.0 KB
Accession
0001723128-19-000042
Insider Transaction Report
Form 4
Stewart Robert A
DirectorPresident & CEO
Transactions
- Purchase
Class A Common Stock
2019-03-12$11.92/sh+17,000$202,640→ 17,000 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 per share to $11.94 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001476493
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:49 PM ET
- Size
- 5.0 KB